What Is Diabetic Retinopathy?

​

Diabetic retinopathy (DR) is a diabetes-related eye disease that affects the blood vessels of the retina, the light-sensitive tissue at the back of the eye responsible for vision.

​

Over time, high blood sugar levels can damage retinal blood vessels, leading to leakage, swelling, bleeding, or reduced blood flow within the retina. Diabetic retinopathy may progress gradually and, in some cases, can lead to significant vision loss if left untreated.

​

There are two primary stages of diabetic retinopathy:

​

• Non-Proliferative Diabetic Retinopathy (NPDR):
  An earlier stage where damaged retinal blood vessels may leak fluid or blood.

• Proliferative Diabetic Retinopathy (PDR):
  A more advanced stage where abnormal new blood vessels grow on the retina and may cause bleeding or retinal complications.​

​

Regular diabetic eye examinations are important for early detection and management.

​

Common Symptoms

​

Symptoms of diabetic retinopathy may include:

​

• Blurred or fluctuating vision

• Dark spots or floaters

• Difficulty reading or focusing

• Areas of missing vision

• Impaired night vision

• Sudden vision changes in advanced cases

​​

Some patients may have no noticeable symptoms during the early stages of the disease.

​

Why Clinical Trials Matter

​

Clinical trials for diabetic retinopathy help researchers evaluate new approaches aimed at preserving vision, slowing disease progression, and improving patient outcomes.

​

Research studies may investigate new medications, imaging technologies, laser treatments, surgical approaches, or long-acting therapies for patients with NPDR or PDR. Participation in clinical research also helps advance future treatment options for individuals living with diabetic eye disease.

​

Each study has specific eligibility requirements, and participation is always voluntary.